BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24744505)

  • 1. Could biomarkers of bone, cartilage or synovium turnover be used for relapse prediction in rheumatoid arthritis patients?
    Dénarié D; Constant E; Thomas T; Marotte H
    Mediators Inflamm; 2014; 2014():537324. PubMed ID: 24744505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage.
    Garnero P; Piperno M; Gineyts E; Christgau S; Delmas PD; Vignon E
    Ann Rheum Dis; 2001 Jun; 60(6):619-26. PubMed ID: 11350852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis.
    Garnero P; Gineyts E; Christgau S; Finck B; Delmas PD
    Arthritis Rheum; 2002 Jan; 46(1):21-30. PubMed ID: 11817593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary excretion of glucosyl-galactosyl pyridinoline: a specific biochemical marker of synovium degradation.
    Gineyts E; Garnero P; Delmas PD
    Rheumatology (Oxford); 2001 Mar; 40(3):315-23. PubMed ID: 11285380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cartilage and bone biomarkers in rheumatoid arthritis: prediction of 10-year radiographic progression.
    Syversen SW; Goll GL; van der Heijde D; Landewé R; Gaarder PI; Odegård S; Haavardsholm EA; Kvien TK
    J Rheumatol; 2009 Feb; 36(2):266-72. PubMed ID: 19132792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of infliximab therapy on biological markers of synovium activity and cartilage breakdown in patients with rheumatoid arthritis.
    Marotte H; Gineyts E; Miossec P; Delmas PD
    Ann Rheum Dis; 2009 Jul; 68(7):1197-200. PubMed ID: 18713784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ibuprofen on molecular markers of cartilage and synovium turnover in patients with knee osteoarthritis.
    Gineyts E; Mo JA; Ko A; Henriksen DB; Curtis SP; Gertz BJ; Garnero P; Delmas PD
    Ann Rheum Dis; 2004 Jul; 63(7):857-61. PubMed ID: 15194584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cartilage oligomeric matrix protein (COMP): the role of a non-collagen cartilage matrix protein as a marker of disease activity and joint destruction in patients with rheumatoid arthritis and osteoarthritis].
    Marti C; Neidhart M; Gerber T; Hauser N; Michel BA; Häuselmann HJ
    Z Rheumatol; 1999 Apr; 58(2):79-87. PubMed ID: 10408068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Connective tissue metabolism in patients with unclassified polyarthritis and early rheumatoid arthritis. Relationship to disease activity, bone mineral density, and radiographic outcome.
    Jensen T; Klarlund M; Hansen M; Jensen KE; Skjødt H; Hyldstrup L;
    J Rheumatol; 2004 Sep; 31(9):1698-708. PubMed ID: 15338487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum and synovial cartilage oligomeric matrix protein levels in early and established rheumatoid arthritis.
    El Defrawy AO; Gheita TA; Raslan HM; El Ansary MM; El Awar AH
    Z Rheumatol; 2016 Nov; 75(9):917-923. PubMed ID: 26683321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum concentrations of formation (PINP) and resorption (Ctx) bone turnover markers in rheumatoid arthritis.
    Wisłowska M; Jakubicz D; Stepień K; Cicha M
    Rheumatol Int; 2009 Oct; 29(12):1403-9. PubMed ID: 19219607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Repair of bone and articular destruction in rheumatoid arthritis].
    Kanbe K
    Clin Calcium; 2007 Apr; 17(4):541-5. PubMed ID: 17404483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of cartilage and bone macromolecules into synovial fluid: differences between psoriatic arthritis and rheumatoid arthritis.
    Mânsson B; Gülfe A; Geborek P; Heinegård D; Saxne T
    Ann Rheum Dis; 2001 Jan; 60(1):27-31. PubMed ID: 11114278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation between synovial TRAF6 expression and serum bone metabolism markers in rheumatoid arthritis].
    Zhu L; Ouyang X; Zheng D; Ma J; Chen L; Wei X; Mo Y; Dai L
    Zhonghua Yi Xue Za Zhi; 2014 Jun; 94(21):1643-6. PubMed ID: 25152288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis and prediction of joint destruction found in patients with rheumatoid arthritis using by biochemical markers].
    Eguchi K
    Nihon Rinsho; 2005 Sep; 63(9):1586-93. PubMed ID: 16164216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synovium CD20 expression is a potential new predictor of bone erosion progression in very-early arthritis treated by sequential DMARDs monotherapy -- a pilot study from the VErA cohort.
    Lanfant-Weybel K; Michot C; Daveau R; Milliez PY; Auquit-Auckbur I; Fardellone P; Brazier M; Mejjad O; Daragon A; Krzanowska K; Jouen F; Tron F; Le Loarer F; Le Loët X; Vittecoq O
    Joint Bone Spine; 2012 Dec; 79(6):574-80. PubMed ID: 22459417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cross sectional study of bone and cartilage biomarkers: correlation with structural damage in rheumatoid arthritis.
    Ben Achour W; Bouaziz M; Mechri M; Zouari B; Bahlous A; Abdelmoula L; Laadhar L; Sellami M; Sahli H; Cheour E
    Libyan J Med; 2018 Dec; 13(1):1512330. PubMed ID: 30160204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone- and cartilage-protective effects of a monoclonal antibody against colony-stimulating factor 1 receptor in experimental arthritis.
    Toh ML; Bonnefoy JY; Accart N; Cochin S; Pohle S; Haegel H; De Meyer M; Zemmour C; Preville X; Guillen C; Thioudellet C; Ancian P; Lux A; Sehnert B; Nimmerjahn F; Voll RE; Schett G
    Arthritis Rheumatol; 2014 Nov; 66(11):2989-3000. PubMed ID: 24623505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas receptor induces apoptosis of synovial bone and cartilage progenitor populations and promotes bone loss in antigen-induced arthritis.
    Lazić Mosler E; Lukač N; Flegar D; Fadljević M; Radanović I; Cvija H; Kelava T; Ivčević S; Šućur A; Markotić A; Katavić V; Marušić A; Grčević D; Kovačić N
    FASEB J; 2019 Mar; 33(3):3330-3342. PubMed ID: 30383451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis.
    Chabaud M; Lubberts E; Joosten L; van Den Berg W; Miossec P
    Arthritis Res; 2001; 3(3):168-77. PubMed ID: 11299057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.